210 related articles for article (PubMed ID: 21130506)
1. Emerging therapies in the treatment of 'diabesity': beyond GLP-1.
Tharakan G; Tan T; Bloom S
Trends Pharmacol Sci; 2011 Jan; 32(1):8-15. PubMed ID: 21130506
[TBL] [Abstract][Full Text] [Related]
2. Gut hormones as therapeutic agents in treatment of diabetes and obesity.
Tan T; Bloom S
Curr Opin Pharmacol; 2013 Dec; 13(6):996-1001. PubMed ID: 24060699
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal hormones and bariatric surgery-induced weight loss.
Ionut V; Burch M; Youdim A; Bergman RN
Obesity (Silver Spring); 2013 Jun; 21(6):1093-103. PubMed ID: 23512841
[TBL] [Abstract][Full Text] [Related]
4. Gut hormones as peripheral anti obesity targets.
Small CJ; Bloom SR
Curr Drug Targets CNS Neurol Disord; 2004 Oct; 3(5):379-88. PubMed ID: 15544446
[TBL] [Abstract][Full Text] [Related]
5. Treating obesity: is it all in the gut?
Davenport RJ; Wright S
Drug Discov Today; 2014 Jul; 19(7):845-58. PubMed ID: 24291217
[TBL] [Abstract][Full Text] [Related]
6. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery.
Holst JJ
Curr Opin Pharmacol; 2013 Dec; 13(6):983-8. PubMed ID: 24161809
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery.
Karra E; Yousseif A; Batterham RL
Trends Endocrinol Metab; 2010 Jun; 21(6):337-44. PubMed ID: 20133150
[TBL] [Abstract][Full Text] [Related]
8. [Influence of bariatric surgery on remission of type 2 diabetes].
Nalepa P; Piechnik A; Kiersztan A
Postepy Hig Med Dosw (Online); 2011 Dec; 65():804-18. PubMed ID: 22173445
[TBL] [Abstract][Full Text] [Related]
9. Gut check on diabesity: leveraging gut mechanisms for the treatment of type 2 diabetes and obesity.
Will S; Hornigold DC; Baker DJ; Coghlan MP; Mesquita M; Trevaskis JL; Naylor J
Curr Opin Pharmacol; 2017 Dec; 37():10-15. PubMed ID: 28802873
[TBL] [Abstract][Full Text] [Related]
10. Gut hormone polyagonists for the treatment of type 2 diabetes.
Brandt SJ; Götz A; Tschöp MH; Müller TD
Peptides; 2018 Feb; 100():190-201. PubMed ID: 29412819
[TBL] [Abstract][Full Text] [Related]
11. Gut Peptide Agonism in the Treatment of Obesity and Diabetes.
Grandl G; Novikoff A; DiMarchi R; Tschöp MH; Müller TD
Compr Physiol; 2019 Dec; 10(1):99-124. PubMed ID: 31853954
[TBL] [Abstract][Full Text] [Related]
12. The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones.
Meek CL; Lewis HB; Reimann F; Gribble FM; Park AJ
Peptides; 2016 Mar; 77():28-37. PubMed ID: 26344355
[TBL] [Abstract][Full Text] [Related]
13. Bariatric surgeries: beyond restriction and malabsorption.
Sandoval D
Int J Obes (Lond); 2011 Sep; 35 Suppl 3():S45-9. PubMed ID: 21912388
[TBL] [Abstract][Full Text] [Related]
14. Narrative review: effect of bariatric surgery on type 2 diabetes mellitus.
Vetter ML; Cardillo S; Rickels MR; Iqbal N
Ann Intern Med; 2009 Jan; 150(2):94-103. PubMed ID: 19153412
[TBL] [Abstract][Full Text] [Related]
15. Bariatric surgery and the gut-brain communication--the state of the art three years later.
Diniz Mde F; Azeredo Passos VM; Diniz MT
Nutrition; 2010 Oct; 26(10):925-31. PubMed ID: 20392599
[TBL] [Abstract][Full Text] [Related]
16. Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP): evidence and clinical opportunity for development of new obesity-diabetes drugs?
Flatt PR
Diab Vasc Dis Res; 2007 Jun; 4(2):151-3. PubMed ID: 17654450
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.
Skow MA; Bergmann NC; Knop FK
Diabetes Obes Metab; 2016 Sep; 18(9):847-54. PubMed ID: 27160961
[TBL] [Abstract][Full Text] [Related]
18. Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery?
Kokkinos A; Tsilingiris D; le Roux CW; Rubino F; Mantzoros CS
Metabolism; 2019 Nov; 100():153960. PubMed ID: 31412266
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms responsible for excess weight loss after bariatric surgery.
Ionut V; Bergman RN
J Diabetes Sci Technol; 2011 Sep; 5(5):1263-82. PubMed ID: 22027328
[TBL] [Abstract][Full Text] [Related]
20. Cracking the combination: Gut hormones for the treatment of obesity and diabetes.
Alexiadou K; Anyiam O; Tan T
J Neuroendocrinol; 2019 May; 31(5):e12664. PubMed ID: 30466162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
